Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

GENERAL COUNSEL

CHIEF MEDICAL OFFICER

CHIEF OPERATING OFFICER

PRESIDENT AND CEO

Chief Medical Officer

Chief Operating Officer

President and CEO

Chief Financial Officer

Chief Informatics Officer

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platfo...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	GENERAL COUNSEL
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT AND CEO
2023-09-18	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-09-18	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-06-13	Premium	bought	Premium	Premium	Premium	-
2023-05-16	Premium	bought	Premium	Premium	Premium	President and CEO
2023-05-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Operating Officer
2023-05-12	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2023-05-12	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-08-15	Premium	sold	Premium	Premium	Premium	-
2022-08-15	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-05-13	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-05-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Operating Officer
2022-05-12	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2021-12-30	Premium	gifted	Premium	Premium	Premium	Chief Informatics Officer
2021-11-29	Premium	bought	Premium	Premium	Premium	President and CEO
2021-11-19	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

BNGO - BioNano Genomics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for BNGO